Skip to main content

Mini-Review: Recent Developments in Hydroxynitrile Lyases for Industrial Biotechnology

Buy Article:

$68.00 + tax (Refund Policy)

Hydroxynitrile lyases (HNLs) catalyze the cleavage as well as the formation of cyanohydrins. The latter reaction is valuable for the stereoselective C-C bond formation by condensation of HCN with carbonyl compounds. The resulting cyanohydrins serve as versatile building blocks for a broad range of chemical and enzymatic follow-up reactions. A significant number of (R)- and (S)-selective HNLs are known today and the number is still increasing. HNLs not only exhibit varying substrate scope but also differ in sequence and structure. Tailor-made enzymes for large-scale manufacturing of cyanohydrins with improved yield and enantiomeric excess are very interesting targets, which is reflected in a solid number of patents. This review will complement and extend our recent review with a strong focus on applications of HNLs for the synthesis of highly functionalized, chiral compounds with newest literature, recent and current patent literature.

Keywords: Asymmetric synthesis; C-C coupling; HNL; biocatalysis; biotransformation; cascade reactions; chiral building blocks; cyanogenesis; cyanohydrin; enantioselectivity; enzyme engineering; hydrocyanic acid; hydroxynitrile lyase; industrial process; mandelonitrile lyase; oxynitrilase; plant enzymes; stereoselective

Document Type: Research Article

Publication date: December 1, 2013

More about this publication?
  • Recent Patents on Biotechnology publishes review articles by experts on recent patents on biotechnology. A selection of important and recent patents on biotechnology is also included in the journal. The journal is essential reading for all researchers involved in all fields of biotechnology.
  • Editorial Board
  • Information for Authors
  • Subscribe to this Title
  • Ingenta Connect is not responsible for the content or availability of external websites
  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content